ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,390,642, issued on Aug. 19, was assigned to LivaNova USA Inc. (Houston).
"Stimulation suspension in response to patient discomfort or state" was invented by Imad Libbus (St. Paul, Minn.), Scott R. Stubbs (Maple Grove, Minn.) and Bruce H. Kenknight (Maple Grove, Minn.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Systems and methods are provided for delivering neurostimulation therapies to patients. Stimulation from an implantable medical device (IMD) may be suspended in response to detecting a patient discomfort event, such as a cough, throat irritation, or voice alteration. The suspension period may be based on at least one of a severity level of the ...